Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TMDX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TMDX investment potential.

What is TMDX stock price today?

Get real-time TMDX stock price, historical data, and price charts on Financhill. Track TMDX performance with our advanced analysis tools.

Is TMDX a good investment?

Evaluate TMDX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TMDX stock?

To buy TMDX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TMDX?

View detailed market capitalization data and company valuation metrics for TMDX on our comprehensive analysis page.

What is the P/E ratio of TMDX?

Use our fundamental analysis tools to view TMDX P/E ratio and compare valuation metrics with industry peers.

What are TMDX earnings?

View TMDX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

TransMedics Group, Inc. Stock Predictions

When an AI Platform Gets Pulled by Too Much Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

TMDX
TransMedics Group, Inc.

Last Price:

$133.19

Seasonality Move:

29.03%

7 Day Trial

ALL ACCESS PASS

$ 7

$10K Investment in Nvidia Could've Made $2.5M

TransMedics Group, Inc. Stock Forecast

Over the next 52 weeks, TransMedics Group, Inc. has on average historically risen by 73.6% based on the past 6 years of stock performance.
TransMedics Group, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is TransMedics Group, Inc. Stock Undervalued?

The current TransMedics Group, Inc. [TMDX] share price is $129.60. The Score for TMDX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
TMDX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will TransMedics Group, Inc. Stock Go Up Next Year?

Over the next 52 weeks, TransMedics Group, Inc. has on average historically risen by 73.6% based on the past 6 years of stock performance.

TransMedics Group, Inc. Stock Rating

Buy

TransMedics Group, Inc. (TMDX) is a Buy

Is TransMedics Group, Inc. overpriced?

TransMedics Group, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

TransMedics Group, Inc. Stock Price History

Is TMDX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Health Care Equipment & Supplies

Sector:

Health Care

Type:

stock

Website:

transmedics.com

52-Week Data

52-Week High:

156.00

52-Week Low:

62.07

Prediction Charts

Market Cap:

4.4B

Price in USD:

129.60

Volume:

814.4K

Beta:

2.00

Technical Analysis

SMA50:

134.15

SMA100:

127.14

SMA200:

122.58

52-Wk Change:

73.8%

Stock Predictions

Is TransMedics Group, Inc. stock public?

Yes, TransMedics Group, Inc. is a publicly traded company.
What is the TransMedics Group, Inc. stock quote today?

The TransMedics Group, Inc. stock price is 129.60 USD today.
How to buy TransMedics Group, Inc. stock online?

You can buy TransMedics Group, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-16	143.51	143.37	149.22	140.41
Jan-20	140.95	141.93	145.13	138.85
Jan-21	142.84	133.81	142.84	132.50
Jan-22	133.60	138.09	141.00	132.02
Jan-23	137.68	135.30	138.95	135.03
Jan-26	135.40	139.33	139.56	132.81
Jan-27	139.99	138.49	141.23	137.61
Jan-28	139.03	140.99	145.74	135.32
Jan-29	143.59	138.97	144.80	135.40
Jan-30	136.39	133.98	139.46	132.01
Feb-2	133.18	133.99	138.16	132.07
Feb-3	135.00	135.72	139.60	132.88
Feb-4	135.16	130.37	135.16	127.14
Feb-5	127.28	129.60	132.19	127.00

TransMedics Group, Inc. Earnings

TransMedics Group, Inc. Earnings Report: Per Share TransMedics Group, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

TransMedics Group, Inc. Forecast Revenue Growth

TransMedics Group, Inc. Stock Analysis: Historical quarterly revenues per share for TransMedics Group, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.74 per share.

* TransMedics Group, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.